1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market – By Technology

1.3.2        Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market – By Application

1.3.3        Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market – By End-User

1.3.4        Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market – By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Circulating Tumor Cell (CTC) Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East & Africa PEST Analysis

4.3         Experts Opinion

5.           Circulating Tumor Cell (CTC) Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Rising Demand for Minimally Invasive Diagnostic Procedures

5.2         Market Restraints

5.2.1        Dearth of Skilled Professionals Performing Diagnostic Procedures

5.3         Market Opportunities

5.3.1        Untapped Potential of Emerging Economies

5.4         Future Trends

5.4.1        Technological Advancements in Isolation of Circulating Tumor Cell

5.5         Impact Analysis

6.           Circulating Tumor Cell (CTC) Diagnostics Market– Middle East & Africa Analysis

6.1         Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis

7.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Technology

7.1         Overview

7.2         Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2020 & 2028 (%)

7.3         CTC detection and Enrichment Method

7.3.1        Overview

7.3.2        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.4         CTC Direct Detection Method

7.4.1        Overview

7.4.2        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.5         CTC Analysis

7.5.1        Overview

7.5.2        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Application

8.1         Overview

8.2         Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share, By Application - 2020 & 2028 (%)

8.3         Clinical/Liquid Biopsy

8.3.1        Overview

8.3.2        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        Risk Assessment

8.3.3.1          Overview

8.3.3.2          Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Screening and Monitoring

8.3.4.1          Overview

8.3.4.2          Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Research

8.4.1        Overview

8.4.2        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.1          Cancer Stem Cell & Tumorigenesis Research

8.4.2.1.1          Overview

8.4.2.1.2          Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.2          Drug/Therapy Development

8.4.2.2.1          Overview

8.4.2.2.2          Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – End user

9.1         Overview

9.2         Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Research and Academic Institutes

9.4.1        Overview

9.4.2        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Centers

9.5.1        Overview

9.5.2        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market – Geographic Analysis

10.1      Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028

10.1.1     Overview

10.1.2     Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.3     Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.1.4     Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)

10.1.4.1       Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.4.2       Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.5     Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

10.1.6     Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Country (%)

10.1.6.1       UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1       Overview

10.1.6.1.2       UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3       UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.1.6.1.4       UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)

10.1.6.1.4.1     UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Research Application (US$ Million)

10.1.6.1.4.2     UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

10.1.6.1.5       UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)

10.1.6.2       Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1       Overview

10.1.6.2.2       Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3       Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.1.6.2.4       Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)

10.1.6.2.4.1     Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Research Application (US$ Million)

10.1.6.2.4.2     Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

10.1.6.2.5       Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)

10.1.6.3       South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1       Overview

10.1.6.3.2       South Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3       South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.1.6.3.4       South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)

10.1.6.3.4.1     South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Research Application (US$ Million)

10.1.6.3.4.2     South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

10.1.6.3.5       South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)

10.1.6.4       Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.1       Overview

10.1.6.4.2       Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.3       Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Technology (US$ Million)

10.1.6.4.4       Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)

10.1.6.4.4.1     Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Research Application (US$ Million)

10.1.6.4.4.2     Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.6.4.5       Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)

11.        Impact of COVID-19 Pandemic on Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market

11.1      Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      THERMO FISHER SCIENTIFIC INC.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      STEMCELL Technologies Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      QIAGEN

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      FLUXION BIOSCIENCES

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Technology (US$ Million)

Table 2.             Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 3.             Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 5.             Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 6.             UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Technology (US$ Million)

Table 7.             UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 8.             UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Research Application (US$ Million)

Table 9.             UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 10.          UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 11.          Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Technology (US$ Million)

Table 12.          Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 13.          Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Research Application (US$ Million)

Table 14.          Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 15.          Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 16.          South Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Technology (US$ Million)

Table 17.          South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 18.          South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Research Application (US$ Million)

Table 19.          South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 20.          South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by End User – (US$ Million)

Table 21.          Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Technology (US$ Million)

Table 22.          Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)

Table 23.          Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 25.          Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 26.          Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 27.          Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 28.          Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market

LIST OF FIGURES

Figure 1.           Circulating Tumor Cell (CTC) Diagnostics Market Segmentation

Figure 2.           Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Overview

Figure 3.           CTC detection and Enrichment Method Held Largest Share of Technology Segment in Circulating Tumor Cell (CTC) Diagnostics Market

Figure 4.           South Africa is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market, Industry Landscape

Figure 6.           Middle East & Africa: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2020 & 2028 (%)

Figure 10.        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 11.        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share, by Application - 2020 & 2028 (%)

Figure 14.        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

Figure 21.        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 25.        Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, By Country (%)

Figure 27.        UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Impact of COVID-19 Pandemic in Middle East & Africa Country Markets

Figure 32.        Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)